OpenURL Connection Search

Select item for more details and to access through your institution.

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
Published in:
2017
By:
- Sekulic, Aleksandar;
- Migden, Michael R.;
- Basset-Seguin, Nicole;
- Garbe, Claus;
- Gesierich, Anja;
- Lao, Christopher D.;
- Miller, Chris;
- Mortier, Laurent;
- Murrell, Dedee F.;
- Hamid, Omid;
- Quevedo, Jorge F.;
- Hou, Jeannie;
- McKenna, Edward;
- Dimier, Natalie;
- Williams, Sarah;
- Schadendorf, Dirk;
- Hauschild, Axel;
- ERIVANCE BCC Investigators
Publication type:
journal article
Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.860421
By:
- Ma, Vincent T.;
- Perera, Alahendra A. Chamila;
- Yilun Sun;
- Sitto, Merna;
- Waninger, Jessica J.;
- Warrier, Govind;
- Green, Michael D.;
- Fecher, Leslie A.;
- Lao, Christopher D.
Publication type:
Article
Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512.
Published in:
PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048787
By:
- Bhatia, Shailender;
- Moon, James;
- Margolin, Kim A.;
- Weber, Jeffrey S.;
- Lao, Christopher D.;
- Othus, Megan;
- Aparicio, Ana M.;
- Ribas, Antoni;
- Sondak, Vernon K.
Publication type:
Article
Concurrent whole brain radiotherapy and bortezomib for brain metastasis.
Published in:
2013
By:
- Lao, Christopher D.;
- Friedman, Judah;
- Tsien, Christina I.;
- Normolle, Daniel P.;
- Chapman, Christopher;
- Cao, Yue;
- Lee, Oliver;
- Schipper, Matt;
- Poznak, Catherine Van;
- Hamstra, Daniel;
- Lawrence, Theodore;
- Hayman, James;
- Redman, Bruce G.;
- Van Poznak, Catherine
Publication type:
journal article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
By:
- Gradone, Allison L.;
- Ma, Vincent T.;
- Vasbinder, Alexi;
- Fecher, Leslie A.;
- Yentz, Sarah;
- Hayek, Salim S.;
- Lao, Christopher D.
Publication type:
Article
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03803-5
By:
- Gradone, Allison L.;
- Ma, Vincent T.;
- Vasbinder, Alexi;
- Fecher, Leslie A.;
- Yentz, Sarah;
- Hayek, Salim S.;
- Lao, Christopher D.
Publication type:
Article
Molecular Diagnostics of Melanoma Fine-Needle Aspirates.
Published in:
American Journal of Clinical Pathology, 2012, v. 138, n. 5, p. 670, doi. 10.1309/AJCPEQJW3PLOOZTC
By:
- Bernacki, Kurt D.;
- Betz, Bryan L.;
- Weigelin, Helmut C.;
- Lao, Christopher D.;
- Redman, Bruce G.;
- Knoepp, Stewart M.;
- Roh, Michael H.
Publication type:
Article
Dose escalation of a curcuminoid formulation.
Published in:
BMC Complementary & Alternative Medicine, 2006, v. 6, p. 10, doi. 10.1186/1472-6882-6-10
By:
- Lao, Christopher D.;
- Ruffin IV, Mack T.;
- Normolle, Daniel;
- Heath, Dennis D.;
- Murray, Sandra I.;
- Bailey, Joanne M.;
- Boggs, Martha E.;
- Crowell, James;
- Rock, Cheryl L.;
- Brenner, Dean E.
Publication type:
Article
Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes.
Published in:
Cancer Medicine, 2023, v. 12, n. 3, p. 2356, doi. 10.1002/cam4.5058
By:
- Balinski, Alexander M.;
- Vasbinder, Alexi L.;
- Kerndt, Connor C.;
- Catalan, Tonimarie C.;
- Parry, Nathan P.;
- Rehman, Rafey A.;
- Blakely, Pennelope;
- Yeow, Raymond Y.;
- Leja, Monika J.;
- Lao, Christopher D.;
- Fecher, Leslie A.;
- Hayek, Salim S.
Publication type:
Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
Published in:
Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
By:
- Tawbi, Hussein A;
- Forsyth, Peter A;
- Hodi, F Stephen;
- Lao, Christopher D;
- Moschos, Stergios J;
- Hamid, Omid;
- Atkins, Michael B;
- Lewis, Karl;
- Thomas, Reena P;
- Glaspy, John A;
- Jang, Sekwon;
- Algazi, Alain P;
- Khushalani, Nikhil I;
- Postow, Michael A;
- Pavlick, Anna C;
- Ernstoff, Marc S;
- Reardon, David A;
- Puzanov, Igor;
- Kudchadkar, Ragini R;
- Tarhini, Ahmad A
Publication type:
Article
Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases.
Published in:
Neuro-Oncology, 2016, v. 18, n. 3, p. 455, doi. 10.1093/neuonc/nov317
By:
- Kim, Michelle M.;
- Parmar, Hemant;
- Yue Cao;
- Knox, Susan J.;
- Oronsky, Bryan;
- Scicinski, Jan;
- Lawrence, Theodore S.;
- Lao, Christopher D.
Publication type:
Article
Strategies for prevention of colorectal cancer: pharmaceutical and nutritional interventions.
Published in:
2004
By:
- Lao, Christopher;
- Brenner, Dean;
- Lao, Christopher D;
- Brenner, Dean E
Publication type:
journal article
Merkel Cell Carcinoma: Critical Review With Guidelines for Multidisciplinary Management.
Published in:
Cancer (0008543X), 2007, v. 110, n. 1, p. 1, doi. 10.1002/cncr.22765
By:
- Bichakjian, Christopher K.;
- Lowe, Lori;
- Lao, Christopher D.;
- Sandler, Howard M.;
- Bradford, Carol R.;
- Johnson, Timothy M.;
- Wong, Sandra L.
Publication type:
Article
Dysplasia in Barrett esophagus.
Published in:
Cancer (0008543X), 2004, v. 100, n. 8, p. 1622
By:
- Christopher D. Lao;
- Melanie Simmons;
- Sapna Syngal;
- Robert S. Bresalier;
- Laurie Fortlage;
- Daniel Normolle;
- Kent A. Griffith;
- Henry D. Appelman
Publication type:
Article
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
Published in:
2018
By:
- Lin, Heng;
- Wei, Shuang;
- Hurt, Elaine M;
- Green, Michael D;
- Zhao, Lili;
- Vatan, Linda;
- Szeliga, Wojciech;
- Herbst, Ronald;
- Harms, Paul W;
- Fecher, Leslie A;
- Vats, Pankaj;
- Chinnaiyan, Arul M;
- Lao, Christopher D;
- Lawrence, Theodore S;
- Wicha, Max;
- Hamanishi, Junzo;
- Mandai, Masaki;
- Kryczek, Ilona;
- Zou, Weiping
Publication type:
journal article
Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
Published in:
2019
By:
- Sekulic, Aleksandar;
- Migden, Michael R.;
- Basset-Seguin, Nicole;
- Garbe, Claus;
- Gesierich, Anja;
- Lao, Christopher D.;
- Miller, Chris;
- Mortier, Laurent;
- Murrell, Dedee F.;
- Hamid, Omid;
- Quevedo, Jorge F.;
- Hou, Jeannie;
- McKenna, Edward;
- Dimier, Natalie;
- Williams, Sarah;
- Schadendorf, Dirk;
- Hauschild, Axel;
- ERIVANCE BCC Investigators
Publication type:
journal article
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Published in:
2017
By:
- Kalinsky, Kevin;
- Lee, Sandra;
- Rubin, Krista M.;
- Lawrence, Donald P.;
- Iafrarte, Anthony J.;
- Borger, Darell R.;
- Margolin, Kim A.;
- Leitao, Mario M.;
- Tarhini, Ahmad A.;
- Koon, Henry B.;
- Pecora, Andrew L.;
- Jaslowski, Anthony J.;
- Cohen, Gary I.;
- Kuzel, Timothy M.;
- Lao, Christopher D.;
- Kirkwood, John M.;
- Leitao, Mario M Jr
Publication type:
journal article
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
Published in:
Oncologist, 2017, v. 22, n. 6, p. 709, doi. 10.1634/theoncologist.2016-0487
By:
- Larkin, James;
- Chmielowski, Bartosz;
- Lao, Christopher D.;
- Hodi, F. Stephen;
- Sharfman, William;
- Weber, Jeffrey;
- Suijkerbuijk, Karijn P. M.;
- Azevedo, Sergio;
- Li, Hewei;
- Reshef, Daniel;
- Avila, Alexandre;
- Reardon, David A.
Publication type:
Article
Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents.
Published in:
Oncologist, 2016, v. 21, n. 10, p. 1230, doi. 10.1634/theoncologist.2016-0055
By:
- Weber, Jeffrey S.;
- Postow, Michael;
- Lao, Christopher D.;
- Schadendorf, Dirk
Publication type:
Article
Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.855794
By:
- Homan, Morgan;
- Warrier, Govind;
- Lao, Christopher D.;
- Yentz, Sarah;
- Kraft, Shawna;
- Fecher, Leslie A.
Publication type:
Article
Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
Published in:
Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 7, p. 800, doi. 10.1111/apt.15413
By:
- Tsung, Irene;
- Dolan, Russell;
- Lao, Christopher D.;
- Fecher, Leslie;
- Riggenbach, Kane;
- Yeboah‐Korang, Amoah;
- Fontana, Robert J.
Publication type:
Article
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Published in:
2014
By:
- Carvajal, Richard D;
- Sosman, Jeffrey A;
- Quevedo, Jorge Fernando;
- Milhem, Mohammed M;
- Joshua, Anthony M;
- Kudchadkar, Ragini R;
- Linette, Gerald P;
- Gajewski, Thomas F;
- Lutzky, Jose;
- Lawson, David H;
- Lao, Christopher D;
- Flynn, Patrick J;
- Albertini, Mark R;
- Sato, Takami;
- Lewis, Karl;
- Doyle, Austin;
- Ancell, Kristin;
- Panageas, Katherine S;
- Bluth, Mark;
- Hedvat, Cyrus
Publication type:
journal article
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma.
Published in:
JAMA: Journal of the American Medical Association, 2014, v. 311, n. 23, p. 2397, doi. 10.1001/jama.2014.6096
By:
- Carvajal, Richard D.;
- Sosman, Jeffrey A.;
- Quevedo, Jorge Fernando;
- Milhem, Mohammed M.;
- Joshua, Anthony M.;
- Kudchadkar, Ragini R.;
- Linette, Gerald P.;
- Gajewski, Thomas F.;
- Lutzky, Jose;
- Lawson, David H.;
- Lao, Christopher D.;
- Flynn, Patrick J.;
- Albertini, Mark R.;
- Sato, Takami;
- Lewis, Karl;
- Doyle, Austin;
- Ancell, Kristin;
- Panageas, Katherine S.;
- Bluth, Mark;
- Hedvat, Cyrus
Publication type:
Article
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma.
Published in:
Pigment Cell & Melanoma Research, 2021, v. 34, n. 3, p. 629, doi. 10.1111/pcmr.12944
By:
- Ma, Vincent T.;
- Daignault‐Newton, Stephanie;
- Waninger, Jessica J.;
- Journey, Sara;
- Chopra, Zoey;
- Tezel, Alangoya;
- Redman, Bruce G.;
- Fecher, Leslie A.;
- Green, Michael D.;
- Alva, Ajjai S.;
- Lao, Christopher D.
Publication type:
Article
V559A and N822I double KIT mutant melanoma with predictable response to imatinib?
Published in:
Pigment Cell & Melanoma Research, 2011, v. 24, n. 2, p. 390, doi. 10.1111/j.1755-148X.2010.00822.x
By:
- McDonnell, Kevin;
- Betz, Bryan;
- Fullen, Douglas;
- Lao, Christopher D.
Publication type:
Article
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Published in:
Cancer (0008543X), 2024, v. 130, n. 10, p. 1784, doi. 10.1002/cncr.35200
By:
- Algazi, Alain P.;
- Moon, James;
- Lao, Christopher D.;
- Chmielowski, Bartosz;
- Kendra, Kari L.;
- Lewis, Karl D.;
- Gonzalez, Rene;
- Kim, Kevin;
- Godwin, John E.;
- Curti, Brendan D.;
- Latkovic-Taber, Michaella;
- Lomeli, Shirley H.;
- Gufford, Brandon T.;
- Scumpia, Philip O.;
- Lo, Roger S.;
- Othus, Megan;
- Ribas, Antoni
Publication type:
Article
Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
Published in:
2020
By:
- Hanks, John E.;
- Kovatch, Kevin J.;
- Ali, S. Ahmed;
- Roberts, Emily;
- Durham, Alison B.;
- Smith, Joshua D.;
- Bradford, Carol R.;
- Malloy, Kelly M.;
- Boonstra, Philip S.;
- Lao, Christopher D.;
- McLean, Scott A.
Publication type:
journal article

Found: 27